Clinical management of immunocompetent hospitalized patients with community-acquired pneumonia

European Journal of Internal Medicine

Volumn 15, Issue 1, 2004, Pages 28-34

  Lamy, Olivier ^a   Van Melle, Guy ^b   Cornuz, Jacques ^a   Burnand, Bernard ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Antibiotherapy; Chest physiotherapy; Clinical practice; Community acquired pneumonia; Guidelines

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CEFTRIAXONE; CEPHALOSPORIN; CLARITHROMYCIN; MACROLIDE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BACTERIAL INFECTION; CHRONIC BRONCHITIS; CLINICAL MEDICINE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; COMPARATIVE STUDY; HUMAN; IMMUNOCOMPETENCE; INSTITUTIONAL CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PHYSIOTHERAPY; PRACTICE GUIDELINE; PROGNOSIS;

EID: 1842559862     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2003.11.003     Document Type: Article

References (41)

1. Bartlett J.G., Mundy L.M. Community-acquired pneumonia. New Engl. J. Med. 333:1995;1618-1624.
2. Marrie T.J. Community-acquired pneumonia. Clin. Infect. Dis. 18:1994;501-515.
3. Jokinen C., Heiskanen L., Juvonen H., et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am. J. Epidemiol. 137:1993;977-988.
4. British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community acquired pneumonia in adults. Thorax. 56:(Suppl. 4):2000;IV1-IV64.
5. Guest J.F., Morris A. Community-acquired pneumonia: the annual cost to the national health service in the UK. Eur. Respir. J. 10:1997;1530-1534.
6. Niederman M.S., MacCombs J.S., Unger A.N., Kumar A., Popovian R. The cost of treating community-acquired pneumonia. Clin. Ther. 20:1998;820-837.
7. Fine M.J., Stone R.A., Singer D.E., Coley C.M., Marrie T.J., Lave J.R. Process and outcomes of care for patients with community-acquired pneumonia. Arch. Intern. Med. 159:1999;970-980.
8. Metlay J.P., Fine M.J., Schultz R., et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J. Gen. Intern. Med. 12:1997;423-430.
9. Bochud P.Y., Moser F., Erard P., et al. Community-acquired pneumonia. A prospective outpatient study. Medicine (Baltimore). 80:2000;75-87.
10. Fine M.J., Smith M.A., Carson C.A., et al. Prognosis and outcome of patients with community-acquired pneumonia. A meta-analysis. J. Am. Med. Assoc. 275:1996;134-141.
11. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am. J. Respir. Crit. Care Med. 163:2001;1730-1754.
12. Galdroni Grassi G., Bianchi L. Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch. Dis. Chest. 50:1995;21-27.
13. Dorca J., Bello S., Blanquer J., et al. The diagnosis and treatment of community-acquired pneumonia. SEPAR Arch. Bronconeumol. 33:1997;240-246.
14. Huchon G., Woodhead M. the members of ESOCAP study group Management of adult community-acquired lower respiratory tract infections. Eur. Respir. J. 11:1998;391-426.
15. Schaberg T., Dalhoff K., Lorenz J., Mauch H., Wilkens H., Witt C. Deutsche Gesellschaft fur pneumololgie: empfehlungen zur diagnostik der ambulant erworbenen pneumonie. Pneumologie. 51:1997;69-77.
16. Schaberg T., Dalhoff K., Ewig S., Lorenz J., Wilkens H. Deutsche Gesellschaft fur pneumololgie: empfehlungen zur therapie der ambulant erworbenen pneumonie. Pneumologie. 52:1998;450-462.
17. Mandell L.A., Marrie T.J., Grossman R.F., Chow A.W., Hyland R.H. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian infectious diseases society and the Canadian thoracic society. Clin. Infect. Dis. 31:2000;383-421.
18. Bartlett J.G., Dowell S.F., Mandell L.A., File T.M., Musher D.M., Fine M.J. Guidelines from the infectious diseases society of America. Practice guidelines for the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 31:2000;347-382.
19. Kenneth G., Gleason P.P., Singer D.E., et al. Variations in antimicrobial use and cost in more than 2000 patients with community-acquired pneumonia. Am. J. Med. 104:1998;17-27.
20. Fine M.J., Medsger A.R., Stone R.A., et al. The hospital discharge decision for patients with community-acquired pneumonia. Arch. Intern. Med. 157:1997;47-56.
21. Schaberg T., Gialdroni-Grassi G., Huchon G., Leophonte P., Manresa F., Woodhead M. An analysis of decisions by European general practitioners to admit to hospital patients with lower respiratory tract infections. Thorax. 51:1996;1017-1022.
22. Fine M.J., Singer D.E., Phelps A.L., Hanusa B.H., Kapoor W.N. Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study. Med. Care. 31:1993;371-380.
23. Lamy O., Zanetti G., Bille J., Aubert J.D., Cornuz J., Burnand B. Diagnostic et traitement de la pneumonie acquise à domicile de l'adulte. Recommandations pour la pratique clinique. Rev. Med. Suisse Romande. 119:1999;403-427.
24. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. New Engl. J. Med. 336:1997;243-250.
25. Marrie T.J., Lau C.Y., Wheeler S.L., Wong C.J., Vandervoort M.K., Feagan B.G. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. J. Am. Med. Assoc. 283:2000;749-755.
26. Meyer R.J., Town G.I., Harré E., Koning M., Hurrel M., Beard M.E.J. An audit of the assessment and management of adults admitted to Christchurch hospital with community-acquired pneumonia. New Zealand Med. J. 110:1997;349-352.
27. Socan M., Marinic-Fiser N., Kraigher A., Kotnik A., Logar M. Microbial etiology of community-acquired pneumonia in hospitalised patients. Eur. J. Clin. Microbiol. Infect. Dis. 18:1999;777-782.
28. Fine M.J., Singer D.E., Hanusa B.H., Lave J.R., Kapoor W.N. Validation of a pneumonia prognostic index using the medisgroups comparative hospital database. Am. J. Med. 94:1993;153-158.
29. Roson B., Carratala J., Dorca J., Casanova A., Manresa F., Gudiol F. Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin. Infect. Dis. 33:2001;158-165.
30. Smith R.P., Lipworth B.J. C-reactive protein in simple community-acquired pneumonia. Chest. 107:1995;1028-1031.
31. Ortqvist A. Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J. Antimicrob. Chemother. 35:1995;205-212.
32. Offman E., Varin F., Nolan T., Bayliff C.D., Bombassaro A.M., McCormack D.G. Oral absorption of clarithromycine in acute illness and during convalescence in patients with community-acquired pneumonia. Chest. 117:2000;1090-1093.
33. Castro-Guardiola A., Viejo-Rodriguez A.L., Soler-Simon S., Armengou-Arxe A., Bisbe-Company V., Penarroja-Matutano G.et al. Efficacy and safety of oral and early-switch therapy for community- acquired pneumonia: a randomized controlled trial. Am. J. Med. 111:2001;367-374.
34. Sanchez F., Mensa J., Martinez J.A., et al. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia? Clin. Infect. Dis. 36:2003;1239-1245.
35. LaForce F.M. Community-acquired lower respiratory tract infections. Prevention and cost-control strategies. Am. J. Med. 78:1985;52-57.
36. Graham W., Bradley D. Efficacity of chest physiotherapy and intermittent positive pressure breathing in the resolution of pneumonia. New Engl. J. Med. 299:1978;624-627.
37. Britton B., Bejstedt M., Vedin L. Chest physiotherapy in primary pneumonia. Br. Med. J. 290:1985;1703-1704.
38. Mittl R.J., Schwab R.J., Duchin J.S., Goin J.E., Albeida S.M., Miller W.T. Radiographic resolution of community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 149:1994;630-635.
39. Meehan T.P., Fine M.J., Krumholz H.M., et al. Quality of care, process, and outcomes in elderly patients with pneumonia. J. Am. Med. Assoc. 278:1997;2080-2084.
40. Benenson R., Magalski A., Cavanaugh S., Wiliams E. Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality. Acad. Emerg. Med. 12:1999;1243-1248.
41. McCormick D., Fine M.J., Coley C.M., et al. Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes? Am. J. Med. 107:1999;5-12.